Midlife predictors of Alzheimer's disease

被引：47

作者：

Bendlin, B. B. ^{[1
,2
]}

Carlsson, C. M. ^{[1
,2
]}

Gleason, C. E. ^{[1
,2
]}

Johnson, S. C. ^{[1
,2
]}

Sodhi, A. ^{[1
,2
]}

Gallagher, C. L. ^{[1
,2
]}

Puglielli, L. ^{[1
,2
]}

Engelman, C. D. ^{[3
]}

Ries, M. L. ^{[1
,2
]}

Xu, G. ^{[1
,2
]}

Wharton, W. ^{[1
,2
]}

Asthana, S. ^{[1
,2
]}

机构：

[1] William S Middleton Mem Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Madison, WI USA

[2] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA

[3] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI USA

来源：

MATURITAS | 2010年 / 65卷 / 02期

关键词：

Alzheimer's disease; Dementia; Midlife; Genes; Family history; Estrogen; Vascular risk; Education; MRI; APOLIPOPROTEIN-E EPSILON-4; ESTROGEN REPLACEMENT THERAPY; GENOME-WIDE ASSOCIATION; SYSTOLIC BLOOD-PRESSURE; WHITE-MATTER INTEGRITY; HEALTH INITIATIVE WHI; WOMENS HEALTH; COGNITIVE FUNCTION; PHYSICAL-ACTIVITY; POSTMENOPAUSAL WOMEN;

D O I：

10.1016/j.maturitas.2009.12.014

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Factors contributing to increased risk for Alzheimer's disease (AD) include age, sex, genes, and family history of AD. Several risk factors for AD are endogenous; however, accumulating evidence implicates modifiable risk factors in the pathogenesis of AD. Although the continued task of identifying new genes will be critical to learning more about the disease, several research findings suggest that potentially alterable environmental factors influence genetic contributions, providing targets for disease prevention and treatment. Here, we review midlife risk factors for AD, and address the potential for therapeutic intervention in midlife. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

引用

页码：131 / 137

页数：7

共 132 条

[21] Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice
Carroll, Jenna C.
Rosario, Emily R.
Chang, Lilly
Stanczyk, Frank Z.
Oddo, Salvatore
LaFerla, Frank M.
Pike, Christian J.
[J]. JOURNAL OF NEUROSCIENCE, 2007, 27 (48) : 13357 - 13365
[22] Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4 Effect
Caselli, Richard J.
Dueck, Amylou C.
Osborne, David
Sabbagh, Marwan N.
Connor, Donald J.
Ahern, Geoffrey L.
Baxter, Leslie C.
Rapcsak, Steven Z.
Shi, Jiong
Woodruff, Bryan K.
Locke, Dona E. C.
Snyder, Charlene Hoffman
Alexander, Gene E.
Rademakers, Rosa
Reiman, Eric M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (03) : 255 - 263
[23] Lack of protective effect of estrogens on cerebral Aβ levels in intact female and male APP transgenic mice
Chakrabarti, E
Wang, J
Claire-Olsen, J
Smith, JD
[J]. DRUG DEVELOPMENT RESEARCH, 2005, 66 (02) : 136 - 141
[24] Chang D, 1997, ADV EXP MED BIOL, V429, P261
[25] The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample
Christensen H.
Batterham P.J.
Mackinnon A.J.
Jorm A.F.
Mack H.A.
Mather K.A.
Anstey K.J.
Sachdev P.S.
Easteal S.
[J]. BMC Geriatrics, 8 (1)
[26] Antecedent biomarkers of Alzheimer's disease: The Adult Children Study
Coats, M
Morris, JC
[J]. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2005, 18 (04) : 242 - 244
[27] Lack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination
Coma, M
Guix, FX
Uribesalgo, I
Espuña, G
Solé, M
Andreu, D
Muñoz, FJ
[J]. BRAIN, 2005, 128 : 1613 - 1621
[28] Apolipoprotein E (APOE) allele distribution in the world.: Is APOE*4 a 'thrifty' allele?
Corbo, RM
Scacchi, R
[J]. ANNALS OF HUMAN GENETICS, 1999, 63 : 301 - 310
[29] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES
CORDER, EH
SAUNDERS, AM
STRITTMATTER, WJ
SCHMECHEL, DE
GASKELL, PC
SMALL, GW
ROSES, AD
HAINES, JL
PERICAKVANCE, MA
[J]. SCIENCE, 1993, 261 (5123) : 921 - 923
[30] Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment
Craft, Suzanne
[J]. CURRENT ALZHEIMER RESEARCH, 2007, 4 (02) : 147 - 152

← 1 2 3 4 5 6 7 8 9 10 →